Aurora Cannabis, Inc. (NYSE: ACB) produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across ...
Cara Therapeutics posts 2018 Revenue 15X over 2017, Questions, Catalysts, and Hurdles Every Marijuana Stock Investor Should be Considering
Cara Therapeutics, Inc. (NASDAQ: CARA), a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a...
Wayland Group is Expanding, Questions, Catalysts, and Hurdles Every Marijuana Stock Investor Should be Considering
Wayland Group Corp. (OTCQB: MRRCF) is a vertically integrated cultivator and processor of cannabis. The Company was founded in 2013 and is based in Bu...
Aphria Continues Expansion, Questions, Catalysts, and Hurdles Every Marijuana Stock Investor Should be Considering
Aphria, Inc. (NYSE: APHA) produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical mar...
The Colorado Legislature is Considering a Change that Could Impact SRC Energy
SRC Energy Inc. (NYSE: SRCI), an oil and natural gas company, engages in the acquisition, exploration, development, and production of oil, natural gas...
How Could the Rowan and Ensco plc Combination Impact Shareholders
Ensco plc (NYSE: ESV) provides offshore contract drilling services to the oil and gas industry worldwide. It operates through three segments: Floaters...
How Might the Immunic Combination with Vital Therapies Impact Investors
Receive our breakout reports in real time text the word TRADERS to 25827 – Traders News Source recent picks, track record and about us – ...
AVEO Pharmaceuticals, Pipeline Review and Potential Catalysts
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) is a biopharmaceutical company, develops and commercializes a portfolio of targeted medicines for oncology a...
Two Months into a Reverse Merger, Where Does Seelos Therapeutics Stand Now?
Seelos Therapeutics Inc. (NASDAQ: SEEL) is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therape...
A Reverse Split and Key Demand Drivers for InspireMD’s Proprietary Technology
InspireMD, Inc. (NYSE: NSPR) is a biotechnology play that has developed a portfolio of medical device assets using a proprietary technology called Mic...